Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions

Rogier A. Van Dijk, Frank Kolodgie, Amir Ravandi, Gregor Leibundgut, Patrick P. Hu, Anand Prasad, Ehtisham Mahmud, Edward Dennis, Linda K. Curtiss, Joseph L. Witztum, Bruce A. Wasserman, Fumiyuki Otsuka, Renu Virmani, Sotirios Tsimikas

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

The relationships between oxidation-specific epitopes (OSE) and lipoprotein (a) [Lp(a)] and progressive atherosclerosis and plaque rupture have not been determined. Coronary artery sections from sudden death victims and carotid endarterectomy specimens were immunostained for apoB-100, oxidized phospholipids (OxPL), apo(a), malondialdehyde- lysine (MDA), and MDA-related epitopes detected by antibody IK17 and macrophage markers. The presence of OxPL captured in carotid and saphenous vein graft distal protection devices was determined with LC-MS/MS. In coronary arteries, OSE and apo(a) were absent in normal coronary arteries and minimally present in early lesions. As lesions progressed, apoB and MDA epitopes did not increase, whereas macrophage, apo(a), OxPL, and IK17 epitopes increased proportionally, but they differed according to plaque type and plaque components. Apo(a) epitopes were present throughout early and late lesions, especially in macrophages and the necrotic core. IK17 and OxPL epitopes were strongest in late lesions in macrophagerich areas, lipid pools, and the necrotic core, and they were most specifically associated with unstable and ruptured plaques. Specific OxPL were present in distal protection devices. Human atherosclerotic lesions manifest a differential expression of OSEs and apo(a) as they progress, rupture, and become clinically symptomatic. These findings provide a rationale for targeting OSE for biotheranostic applications in humans.

Original languageEnglish (US)
Pages (from-to)2773-2790
Number of pages18
JournalJournal of Lipid Research
Volume53
Issue number12
DOIs
StatePublished - Dec 1 2012
Externally publishedYes

Fingerprint

Apoprotein(a)
Epitopes
Oxidation
Phospholipids
Macrophages
Malondialdehyde
Lysine
Coronary Vessels
Rupture
Apolipoprotein B-100
Equipment and Supplies
Lipoprotein(a)
Carotid Endarterectomy
Saphenous Vein
Apolipoproteins B
Sudden Death
Grafts
Atherosclerosis
Transplants
Lipids

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions. / Van Dijk, Rogier A.; Kolodgie, Frank; Ravandi, Amir; Leibundgut, Gregor; Hu, Patrick P.; Prasad, Anand; Mahmud, Ehtisham; Dennis, Edward; Curtiss, Linda K.; Witztum, Joseph L.; Wasserman, Bruce A.; Otsuka, Fumiyuki; Virmani, Renu; Tsimikas, Sotirios.

In: Journal of Lipid Research, Vol. 53, No. 12, 01.12.2012, p. 2773-2790.

Research output: Contribution to journalArticle

Van Dijk, RA, Kolodgie, F, Ravandi, A, Leibundgut, G, Hu, PP, Prasad, A, Mahmud, E, Dennis, E, Curtiss, LK, Witztum, JL, Wasserman, BA, Otsuka, F, Virmani, R & Tsimikas, S 2012, 'Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions', Journal of Lipid Research, vol. 53, no. 12, pp. 2773-2790. https://doi.org/10.1194/jlr.P030890
Van Dijk, Rogier A. ; Kolodgie, Frank ; Ravandi, Amir ; Leibundgut, Gregor ; Hu, Patrick P. ; Prasad, Anand ; Mahmud, Ehtisham ; Dennis, Edward ; Curtiss, Linda K. ; Witztum, Joseph L. ; Wasserman, Bruce A. ; Otsuka, Fumiyuki ; Virmani, Renu ; Tsimikas, Sotirios. / Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions. In: Journal of Lipid Research. 2012 ; Vol. 53, No. 12. pp. 2773-2790.
@article{f5da6b19f9f7435aa96ace6e8c20a103,
title = "Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions",
abstract = "The relationships between oxidation-specific epitopes (OSE) and lipoprotein (a) [Lp(a)] and progressive atherosclerosis and plaque rupture have not been determined. Coronary artery sections from sudden death victims and carotid endarterectomy specimens were immunostained for apoB-100, oxidized phospholipids (OxPL), apo(a), malondialdehyde- lysine (MDA), and MDA-related epitopes detected by antibody IK17 and macrophage markers. The presence of OxPL captured in carotid and saphenous vein graft distal protection devices was determined with LC-MS/MS. In coronary arteries, OSE and apo(a) were absent in normal coronary arteries and minimally present in early lesions. As lesions progressed, apoB and MDA epitopes did not increase, whereas macrophage, apo(a), OxPL, and IK17 epitopes increased proportionally, but they differed according to plaque type and plaque components. Apo(a) epitopes were present throughout early and late lesions, especially in macrophages and the necrotic core. IK17 and OxPL epitopes were strongest in late lesions in macrophagerich areas, lipid pools, and the necrotic core, and they were most specifically associated with unstable and ruptured plaques. Specific OxPL were present in distal protection devices. Human atherosclerotic lesions manifest a differential expression of OSEs and apo(a) as they progress, rupture, and become clinically symptomatic. These findings provide a rationale for targeting OSE for biotheranostic applications in humans.",
author = "{Van Dijk}, {Rogier A.} and Frank Kolodgie and Amir Ravandi and Gregor Leibundgut and Hu, {Patrick P.} and Anand Prasad and Ehtisham Mahmud and Edward Dennis and Curtiss, {Linda K.} and Witztum, {Joseph L.} and Wasserman, {Bruce A.} and Fumiyuki Otsuka and Renu Virmani and Sotirios Tsimikas",
year = "2012",
month = "12",
day = "1",
doi = "10.1194/jlr.P030890",
language = "English (US)",
volume = "53",
pages = "2773--2790",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "12",

}

TY - JOUR

T1 - Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions

AU - Van Dijk, Rogier A.

AU - Kolodgie, Frank

AU - Ravandi, Amir

AU - Leibundgut, Gregor

AU - Hu, Patrick P.

AU - Prasad, Anand

AU - Mahmud, Ehtisham

AU - Dennis, Edward

AU - Curtiss, Linda K.

AU - Witztum, Joseph L.

AU - Wasserman, Bruce A.

AU - Otsuka, Fumiyuki

AU - Virmani, Renu

AU - Tsimikas, Sotirios

PY - 2012/12/1

Y1 - 2012/12/1

N2 - The relationships between oxidation-specific epitopes (OSE) and lipoprotein (a) [Lp(a)] and progressive atherosclerosis and plaque rupture have not been determined. Coronary artery sections from sudden death victims and carotid endarterectomy specimens were immunostained for apoB-100, oxidized phospholipids (OxPL), apo(a), malondialdehyde- lysine (MDA), and MDA-related epitopes detected by antibody IK17 and macrophage markers. The presence of OxPL captured in carotid and saphenous vein graft distal protection devices was determined with LC-MS/MS. In coronary arteries, OSE and apo(a) were absent in normal coronary arteries and minimally present in early lesions. As lesions progressed, apoB and MDA epitopes did not increase, whereas macrophage, apo(a), OxPL, and IK17 epitopes increased proportionally, but they differed according to plaque type and plaque components. Apo(a) epitopes were present throughout early and late lesions, especially in macrophages and the necrotic core. IK17 and OxPL epitopes were strongest in late lesions in macrophagerich areas, lipid pools, and the necrotic core, and they were most specifically associated with unstable and ruptured plaques. Specific OxPL were present in distal protection devices. Human atherosclerotic lesions manifest a differential expression of OSEs and apo(a) as they progress, rupture, and become clinically symptomatic. These findings provide a rationale for targeting OSE for biotheranostic applications in humans.

AB - The relationships between oxidation-specific epitopes (OSE) and lipoprotein (a) [Lp(a)] and progressive atherosclerosis and plaque rupture have not been determined. Coronary artery sections from sudden death victims and carotid endarterectomy specimens were immunostained for apoB-100, oxidized phospholipids (OxPL), apo(a), malondialdehyde- lysine (MDA), and MDA-related epitopes detected by antibody IK17 and macrophage markers. The presence of OxPL captured in carotid and saphenous vein graft distal protection devices was determined with LC-MS/MS. In coronary arteries, OSE and apo(a) were absent in normal coronary arteries and minimally present in early lesions. As lesions progressed, apoB and MDA epitopes did not increase, whereas macrophage, apo(a), OxPL, and IK17 epitopes increased proportionally, but they differed according to plaque type and plaque components. Apo(a) epitopes were present throughout early and late lesions, especially in macrophages and the necrotic core. IK17 and OxPL epitopes were strongest in late lesions in macrophagerich areas, lipid pools, and the necrotic core, and they were most specifically associated with unstable and ruptured plaques. Specific OxPL were present in distal protection devices. Human atherosclerotic lesions manifest a differential expression of OSEs and apo(a) as they progress, rupture, and become clinically symptomatic. These findings provide a rationale for targeting OSE for biotheranostic applications in humans.

UR - http://www.scopus.com/inward/record.url?scp=84869074308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869074308&partnerID=8YFLogxK

U2 - 10.1194/jlr.P030890

DO - 10.1194/jlr.P030890

M3 - Article

C2 - 22969153

AN - SCOPUS:84869074308

VL - 53

SP - 2773

EP - 2790

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 12

ER -